Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

260
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
260
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

920
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
920
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

523
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

166
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
166

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of bone health in adult solid organ transplant recipients: a multidisciplinary care pathway.

Clinical transplantation and research·2026
Same author

Continuous Glucose Monitoring for Postkidney Transplantation in Patient With Pre-existing Type 2 Diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Insulin Pump Guide for Health Care Professionals: Settings, Interpretation, and Adjustment.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.

The lancet. Diabetes & endocrinology·2025
Same author

The Technologic Transformation in Diabetes Care: From Continuous Glucose Monitoring to Artificial Intelligence and Beyond.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

Compounded incretins in clinical practice: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy.

Diabetes & metabolic syndrome·2025

Related Experiment Video

Updated: Jun 24, 2025

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

16.2K

Diabetes technology: A primer for clinicians.

Jayachidambaram Ambalavanan1, Diana Isaacs2, M Cecilia Lansang3

  • 1Clinical Fellow, Department of Endocrinology, Diabetes, and Metabolism, Medical Specialty Institute, Cleveland Clinic, Cleveland, OH.

Cleveland Clinic Journal of Medicine
|June 3, 2024
PubMed
Summary

Diabetes technology, including continuous glucose monitors (CGMs) and insulin pumps, is rapidly advancing. Increased device availability and insurance coverage are improving diabetes management for patients and clinicians.

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.8K

Related Experiment Videos

Last Updated: Jun 24, 2025

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

16.2K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.8K

Area of Science:

  • Endocrinology and Metabolic Diseases
  • Biomedical Engineering
  • Health Informatics

Background:

  • Diabetes management is being transformed by rapidly evolving medical technologies.
  • Growing FDA approvals and insurance coverage are driving widespread adoption of new diabetes devices.
  • Clinicians need to be aware of these advancements to effectively guide patient care.

Purpose of the Study:

  • To summarize currently available diabetes management technologies for healthcare providers.
  • To enhance clinician familiarity with devices encountered in clinical practice.
  • To improve patient access to and utilization of modern diabetes technologies.

Main Methods:

  • Review of commonly available diabetes management devices in the current market.
  • Categorization of technologies including continuous glucose monitors (CGMs), connected insulin delivery devices, and insulin pumps.
  • Focus on devices likely to be encountered by clinicians managing patients with diabetes.

Main Results:

  • Continuous Glucose Monitors (CGMs) offer real-time glucose readings and trend data.
  • Connected insulin pens, caps, and buttons provide data logging and improved insulin dosing accuracy.
  • Insulin pumps deliver basal and bolus insulin, enabling more precise glycemic control.

Conclusions:

  • Increased clinician awareness and familiarity with diabetes technology are crucial.
  • Enhanced understanding will facilitate better patient education and technology adoption.
  • This knowledge empowers clinicians to optimize diabetes care through technological integration.